ESMERON rocuronium bromide 50 mg/5 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

esmeron rocuronium bromide 50 mg/5 ml injection vial

merck sharp & dohme (australia) pty ltd - rocuronium bromide, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; glacial acetic acid; sodium acetate trihydrate - rocuronium is indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, and paediatric patients from term newborn infants to adolescents.,in adults, rocuronium is also indicated as an adjunct to general anaesthesia to facilitate endotracheal,intubation during rapid sequence induction when suxamethonium is contraindicated. in adults, rocuronium is also indicated as an adjunct in the intensive care unit (icu) to facilitate mechanical ventilation.

ESMERON 250 mg=25 ml injection SUSPENSION South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

esmeron 250 mg=25 ml injection suspension

sanofi-aventis south africa (pty) ltd - suspension - 250 mg - each vial contains 25 ml esmeron

ESMERON Israel - English - Ministry of Health

esmeron

merck sharp & dohme (israel - 1996) company ltd, israel - rocuronium bromide - solution for injection - rocuronium bromide 10 mg/ml - rocuronium bromide - rocuronium bromide - adjunct to general anaesthesia to facilitate tracheal intubation, to provide skeletal muscle relaxation during surgery. esmeron indicated as an adjunct in the intensive care unit (icu) to facilitate tracheal intubation and mechanical ventilation.

Esmeron New Zealand - English - Medsafe (Medicines Safety Authority)

esmeron

merck sharp & dohme (new zealand) limited - rocuronium bromide 10 mg/ml;   - solution for injection - 10 mg/ml - active: rocuronium bromide 10 mg/ml   excipient: glacial acetic acid sodium acetate trihydrate sodium chloride water for injection - rocuronium is indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, and paediatric patients from term newborn infants to adolescents.

Esmeron 10 mg/ml solution for injection/infusion Ireland - English - HPRA (Health Products Regulatory Authority)

esmeron 10 mg/ml solution for injection/infusion

merck sharp & dohme ireland (human health) limited - rocuronium bromide - solution for injection/infusion - 10 milligram(s)/millilitre - other quaternary ammonium compounds; rocuronium bromide

Esmeron Australia - English - Department of Health (Therapeutic Goods Administration)

esmeron

merck sharp & dohme australia pty ltd - rocuronium bromide -

ESMERON 10 Mg/Ml Solution for Inj/Inf Ireland - English - HPRA (Health Products Regulatory Authority)

esmeron 10 mg/ml solution for inj/inf

nv organon - rocuronium bromide - solution for inj/inf - 10 mg/ml - other quaternary ammonium compounds

ESMERON INJECTION 50 mg5ml Singapore - English - HSA (Health Sciences Authority)

esmeron injection 50 mg5ml

msd pharma (singapore) pte. ltd. - rocuronium bromide - injection - 10 mg/ml - rocuronium bromide 10 mg/ml

ESMERON 100 mg INJECTION South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

esmeron 100 mg injection

msd (pty) ltd - injection - see ingredients - each 10,0 ml solution contains rocuronium bromide 100,0 mg